Teligent Pharma, Inc. recalls Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59
Teligent Pharma recalls 2% Erythromycin Topical Solution 60mL bottles (Rx only) due to possible container seal failure. Affected lots: 14892 (expiring 1/2022).
Lower-risk recall
Defective container: possibility for lack of seal integrity.
Contact the company & request your remedy
What happened, in plain English
Teligent Pharma is recalling 2% Erythromycin Topical Solution 60mL bottles because the container might not seal properly. This could lead to contamination or medication exposure if the seal fails. Read more at govinfonow.com/recall/36023-teligent-pharma-erythromycin-topical-solution-2-recall-container-seal-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36023-teligent-pharma-erythromycin-topical-solution-2-recall-container-seal-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0769-2021
Cite this page
“Teligent Pharma Erythromycin Topical Solution 2% Recall: Container Seal Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/36023-teligent-pharma-erythromycin-topical-solution-2-recall-container-seal-risk. Based on FDA recall #D-0769-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0769-2021%22&limit=1).
Why it’s dangerous
The container may not seal properly, which could allow contamination or exposure to air. This might lead to medication degradation or skin irritation if the seal fails during use.
Who’s affected
Prescription users who have the 60mL bottle with lot number 14892 (expiring 1/2022). People using the product for skin infections are most at risk if the seal fails.
How to tell if you have this one
Check for the 60mL bottle labeled 'Erythromycin Topical Solution USP 2%' with lot number 14892 (expiring 1/2022). This product is prescription-only and sold by Teligent Pharma.
- Brand
Teligent Pharma- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 14892 on the bottle label, which expires January 2022.
Questions people ask
Is this product safe to use?
The recall states there's a possibility of lack of seal integrity, but the product is still safe to use if the seal remains intact.
How can I tell if I have the recalled product?
Check for the 60mL bottle with lot number 14892 (expiring 1/2022) labeled 'Erythromycin Topical Solution USP 2%'.
What should I do if I have the recalled product?
The recall does not specify a remedy, so contact Teligent Pharma for guidance.
Contact Teligent Pharma
We’ve drafted a message you can send Teligent Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0769-2021 — Teligent Pharma Teligent Pharma Hello, I own a Teligent Pharma that is covered by recall D-0769-2021 from Teligent Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0769-2021 (July 29, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0769-2021 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.